These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19602793)

  • 21. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial.
    Nemec P; Zemanova Z; Kuglik P; Michalova K; Tajtlova J; Kaisarova P; Oltova A; Filkova H; Holzerova M; Balcarkova J; Jarosova M; Rabasova J; Hruba M; Spicka I; Gregora E; Adam Z; Scudla V; Maisnar V; Schutzova M; Hajek R;
    Leuk Lymphoma; 2012 May; 53(5):920-7. PubMed ID: 22023516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma.
    Tirier C; Zhang Y; Plendl H; Weber-Matthiesen K; Langer W; Heit W; Schlegelberger B
    Leukemia; 1996 Feb; 10(2):346-50. PubMed ID: 8637246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiple myeloma with IgH::MYC and multiple extramedullary lesions].
    Sasaki Y; Ichikawa S; Sakurai K; Nakamura H; Inokura K; Onodera K; Fukuhara N; Onishi Y; Yokoyama H; Harigae H
    Rinsho Ketsueki; 2024; 65(3):147-152. PubMed ID: 38569857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia.
    Sandlund JT; Kastan MB; Kennedy W; Behm F; Entrekin E; Pui CH; Kalwinsky DT; Raimondi SC
    Cancer Genet Cytogenet; 2006 Jul; 168(1):69-72. PubMed ID: 16772123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel translocation t(3;11)(p21;q24) in multiple myeloma characterised by FISH.
    Smith A; de Lambert R; Robson L
    Ann Genet; 1999; 42(4):221-4. PubMed ID: 10674162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Coma, hyperviscosity syndrome, hyperammonemia and myelofibrosis in a patient with IgG, lambda type multiple myeloma].
    Tsunoda S; Sasaki R; Miwa A; Sakurabayashi I; Miura Y
    Rinsho Ketsueki; 1989 Mar; 30(3):361-5. PubMed ID: 2504973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperammonemia: elevated ammonia levels in multiple myeloma.
    Holahan JR
    Am J Med; 2004 Feb; 116(3):210-1. PubMed ID: 14749172
    [No Abstract]   [Full Text] [Related]  

  • 29. Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).
    Otsuki T; Wada H; Nakazawa N; Taniwaki M; Kouguchi K; Ohkura M; Uehira K; Isoda K; Yata K; Sakaguchi H; Yawata Y; Ueki A; Yamada O
    Leuk Lymphoma; 2001 Aug; 42(4):761-74. PubMed ID: 11697507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.
    Pham A; Reagan JL; Castillo JJ
    Leuk Res; 2013 Oct; 37(10):1229-32. PubMed ID: 23932549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperammonemia: an unusual presenting feature of multiple myeloma.
    Shah AS; Shetty N; Jaiswal S; Mehta BC
    Indian J Med Sci; 2005 Jan; 59(1):24-7. PubMed ID: 15681889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
    Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
    Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of multiple myeloma (IgG, k) associated with hypertetraploid chromosomal abnormality].
    Koyama R; Nagai T; Sasagawa Y; Matsumoto S; Enomoto K; Yamada T
    Gan No Rinsho; 1988 Feb; 34(2):238-43. PubMed ID: 3126334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The t(8;14)(q24.1;q32) and its variant translocations: A study of 34 cases.
    Angi M; Kamath V; Yuvarani S; Meena J; Sitaram U; Manipadam MT; Nair S; Ganapule A; Fouzia NA; Abraham A; Viswabandya A; Poonkuzhali B; George B; Mathews V; Srivastava A; Srivastava VM
    Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):126-134. PubMed ID: 28390216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26).
    Akalin I; Kutlay NY; Ilhan O; Tukun A
    Int J Lab Hematol; 2007 Jun; 29(3):215-20. PubMed ID: 17474900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.
    Lora-Tamayo J; Palom X; Sarrá J; Gasch O; Isern V; Fernández de Sevilla A; Pujol R
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):363-9. PubMed ID: 19064403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor.
    Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch
    Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperammonemic encephalopathy associated with multiple myeloma.
    López-Blanco R; de Fuenmayor-Fernández de la Hoz CP; González de la Aleja J; Martínez-Sánchez P; Ruiz-Morales J
    Neurologia; 2017 Jun; 32(5):339-341. PubMed ID: 26541697
    [No Abstract]   [Full Text] [Related]  

  • 39. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
    Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
    Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
    Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
    Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.